肝脏 ›› 2020, Vol. 25 ›› Issue (4): 372-374.

• 病毒性肝炎 • 上一篇    下一篇

肾小管HBAg阳性表达与HBV相关肾功能损伤预后的关系

刘栋, 苏康乐, 张翠杰, 翟亚玲, 李芳华   

  1. 450052 郑州大学第一附属医院肾内科
  • 收稿日期:2019-11-05 发布日期:2020-05-09
  • 基金资助:
    中国博士后科学基金(2018M640684);国家科学自然基金项目(81600555)

Relationship between positive expression of HBAg in renal tubules and prognosis of renal function damage associated with hepatitis B virus

LIU dong, SU Kang-le, ZHANG Cui-jie, ZHAI Ya-ling, LI Fang-hua   

  1. Department of Nephrology, the First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan 450052, China
  • Received:2019-11-05 Published:2020-05-09

摘要: 目的 研究肾小管乙型肝炎抗原(HBAg)阳性表达与HBV相关肾功能损伤预后的关系。方法 回顾性分析郑州大学第一附属医院2016年12月至2018年12月收治的80例乙肝相关性肾病(HBV-GN)患者的临床资料,依据肾组织中有无HBAg沉积分为HBAg沉积组与无HBAg沉积组,每组40例。比较两组患者性别、年龄、临床表现、HBsAg、HBeAg、白蛋白、低密度脂蛋白(LDL)、三酰甘油(TG)、胆固醇(TC)、血红蛋白(Hb)、血尿酸(SUA)、血肌酐(Scr)、HBV DNA。logistic回归分析影响HBV-GN患者预后的危险因素。结果 HBAg沉积组男32例,年龄(41.5±9.5)岁,存在肾病综合征24例,存在肾炎综合征22例,白蛋白(54.37±6.43)g/L,LDL(3.84±1.43)mmol/L,TG(1.43±0.84)mmol/L,TC(6.14±1.03)mmol/L,Hb(147.54±20.46)g/L,SUA(382.62±94.57)μmol/L,Scr(133.75±13.76)μmol/L,HBV DNA(5.43±1.42)拷贝/mL。无HBAg沉积组男30例,年龄(41.6±9.5)岁、存在肾病综合征25例,存在肾炎综合征17例,白蛋白(54.40±6.58)g/L,LDL(3.81±1.38)mmol/L,TG(1.44±0.86)mmol/L,TC(6.11±0.93)mmol/L,Hb(146.87±20.41)g/L,SUA(386.54±96.75)μmol/L,Scr(133.70±13.54)μmol/L,HBV DNA(5.57±1.34)拷贝/mL,差异均无统计学意义(P>0.05)。在HBAg沉积组中存在肾功能损害34例、HBsAg阳性35例、HBeAg阳性33例,无HBAg沉积组中存在肾功能损伤19例、HBsAg阳性20例、HBeAg阳性19例(P<0.05)。经多因素Logistic回归性分析证实,存在肾功能损伤,HBsAg、HBeAg阳性为影响HBV-GN患者预后的危险因素(均P<0.05)。结论 影响HBV-GN患者预后的危险因素较多,如肾功能损伤、肾小管HBAg阳性表达等。

关键词: 乙肝相关性肾病, 乙型肝炎抗原, 肾损伤, 预后

Abstract: Objective To study the relationship between positive expression of tubule hepatitis b antigen (HBAg) and prognosis of hepatitis B virus related renal function injury.Methods The clinical data of 80 patients with hepatitis B related nephropathy (HBV-GN) admitted to our hospital from December 2016 to December 2018 were retrospectively analyzed. According to the presence and absence of HBAg deposition in renal tissues, all patients were divided into the HBAg deposition group and the no-HBAg deposition group, with 40 patients in each group.Compare two groups of patients with basic data and laboratory test results, including gender, age, clinical manifestation, the existence of nephrotic syndrome, nephritis syndrome, kidney damage), hepatitis B surface antigen (HBsAg), hepatitis B virus E antigen (HBeAg), albumin (Alb), low density lipoprotein (LDL), triglycerides (TG), cholesterol (TC), hemoglobin (Hb), blood uric acid (SUA), serum creatinine (Scr), hepatitis B virus DNA (HBV DNA);The differentiated information was incorporated into the multivariate Logistic regression model to identify the risk factors affecting the prognosis of HBV-GN patients. Results In the HBAg deposition group, 32 males, aged (41.54 ± 9.46) years, 24 with nephrotic syndrome, 22 with nephritis syndrome, ALB (54.37 ± 6.43) g/L, LDL (3.84 ± 1.43) mmol/L, TG (1.43 ± 0.84) mmol/L, TC (6.14 ± 1.03) mmol/L, Hb (147.54 ± 20.46) g/L, SUA (382.62 ± 94.57) μmol/L, Scr (133.75 ± 13.76) μmol/L, HBV DNA (5.43 ± 1.42) copies/mL and 30 men without HBAg deposition, aged (41.58 ± 9.53) years, 25 with nephrotic syndrome, 17 with nephritis syndrome, ALB (54.40 ± 6.58) g/L, LDL (3.81 ± 1.38) mmol/L, TG (1.44 ± 0.86) mmol/L, TC (6.11 ± 0.93) mmol/L, Hb (146.87 ± 20.41) g/L, SUA (386.54 ± 96.75) μmol/L, There was no significant difference between Scr (133.70 ± 13.54) μmol/L and HBV DNA (5.57 ± 1.34) copies/mL, P>0.05;Renal function impairment was shown in the HBAg deposition group, and patients with positive serum HBsAg and HBeAg were significantly more than those without the HBAg deposition group. (34 with renal impairment, 35 with HBsAg positive, and 33 with HBeAg positive. Twenty cases were HBsAg positive, 19 cases were HBeAg positive, P<0.05).Multivariate Logistic regression analysis confirmed that there was renal impairment. Positive HBsAg and HBeAg were risk factors affecting the prognosis of patients with HBV-GN, both P<0.05.Conclusion There are many risk factors that affect the prognosis of patients with HBV-GN, such as renal function damage and positive expression of renal tubule HBAg, which should be concerned by clinicians in clinical treatment.

Key words: Hepatitis B related nephropathy;Hepatitis B antigen;Kidney injury;The prognosis